XML 15 R5.htm IDEA: XBRL DOCUMENT v3.23.1
CONDENSED CONSOLIDATED STATEMENTS OF COMMON STOCK AND STOCKHOLDERS' EQUITY (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Beginning balance at Dec. 31, 2021 $ 146,513 $ 3 $ 296,049 $ (149,206) $ (333)
Beginning balance, shares at Dec. 31, 2021   30,609,029      
Stock-based compensation expense 1,515   1,515    
Exercise of options into common stock 237   237    
Exercise of options into common stock, shares   73,784      
Employee stock purchase plan expense 14   14    
Unrealized loss on marketable securities (566)       (566)
Net loss (12,405)     (12,405)  
Ending balance at Mar. 31, 2022 135,308 $ 3 297,815 (161,611) (899)
Ending balance, shares at Mar. 31, 2022   30,682,813      
Beginning balance at Dec. 31, 2022 103,407 $ 3 302,202 (197,794) (1,004)
Beginning balance, shares at Dec. 31, 2022   30,764,160      
Stock-based compensation expense 1,213   1,213    
Issuance of equity in exchange for compensation 302   302    
Issuance of equity in exchange for compensation, Shares   208,510      
Surrender of shares for tax withholding (76)   (76)    
Surrender of shares for tax withholding, Shares   (50,343)      
Vesting of restricted stock shares, shares   49,014      
Unrealized loss on marketable securities 181       181
Net loss (10,177)     (10,177)  
Ending balance at Mar. 31, 2023 $ 94,850 $ 3 $ 303,641 $ (207,971) $ (823)
Ending balance, shares at Mar. 31, 2023   30,971,341